Board Member
Medpace Holdings, Inc. (MEDP)Equibles does not estimate personal net worth.
Get an email with a short summary when Medpace Holdings, Inc. publishes a filing, an earnings call transcript or a press release.
Get MEDP alertsAugust Troendle is recorded as Board Member at Medpace Holdings, Inc. (MEDP) since January 1, 1992 and CEO at Medpace Holdings, Inc. (MEDP). The proxy statement of Medpace Holdings, Inc. reports total compensation of $11,443,766 for August Troendle in fiscal 2025, including a base salary of $937,417. Disclosed compensation is on record for 9 fiscal years. August Troendle has spoken on 26 earnings calls across 1 company, most recently for Medpace Holdings, Inc. on July 23, 2026. Medpace Holdings, Inc. is classified in the Diagnostics & Research industry within the Healthcare sector. Other leadership on record at Medpace Holdings, Inc. includes August J. Troendle (CEO and Board Member), Jesse Geiger (CFO), Jesse J. Geiger (CFO) and 7 others.
“The business environment was strong in Q2 2026. Cancellations were well-behaved and supported a record quarter for net bookings. RFPs were up sequentially and year-over-year, generating high-quality opportunities.”
“Before reviewing Q1 results, I would like to acknowledge that this will be our last earnings call with Jesse Geiger, our president. I would like to thank Jesse for his 18 and a half years of service.”
“Cancellations were elevated again in Q4. Backlog cancellations in absolute and percent terms were the highest they had been in over a year. This resulted in a lower than anticipated net book-to-bill ratio of 1.04.”
“Cancellations were well behaved in Q3, permitting record net bookings and a net book-to-bill of 1.20. RFP quality remains solid with decisions progressing at a usual tempo.”
“RFP flow in Q2 continued to be strong, and we saw an increase in the rate of decisions. Total pending RFP dollars were down on the quarter and our award notifications were strong.”
1992-01-01–present
Diagnostics & Research · Healthcare
CEO, Board Member
1992-01-01–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Medpace Holdings, Inc. (MEDP) | CEO | $937,417 | $11,443,766 |
| 2024 | Medpace Holdings, Inc. (MEDP) | CEO | $866,250 | $8,600,016 |
| 2023 | Medpace Holdings, Inc. (MEDP) | CEO | $814,275 | $1,646,031 |
| 2022 | Medpace Holdings, Inc. (MEDP) | CEO | $770,250 | $1,885,034 |
| 2021 | Medpace Holdings, Inc. (MEDP) | CEO | $696,667 | $5,947,423 |
| 2020 | Medpace Holdings, Inc. (MEDP) | CEO | $607,542 | $4,136,810 |
| 2019 | Medpace Holdings, Inc. (MEDP) | — | $503,583 | $7,712,835 |
| 2018 | Medpace Holdings, Inc. (MEDP) | CEO | $420,250 | $528,290 |
| 2017 | Medpace Holdings, Inc. (MEDP) | CEO | $418,542 | $598,083 |
